Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
Submitted by
admin
on April 24, 2014 - 11:36am
Source:
First Word Pharma
News Tags:
Celgene
Nogra Pharma
Crohn's Disease
GED-0301
Headline:
Celgene enters deal potentially worth over $2.5 billion for Nogra Pharma's Crohn's disease drug
Do Not Allow Advertisers to Use My Personal information